Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKainos Group Regulatory News (KNOS)

Share Price Information for Kainos Group (KNOS)

Share Price is delayed by 15 minutes
Get Live Data
849.50    -28.50 (-3.25%)
Bid:
852.50
Ask:
854.50
Spread: 2.00 (0.235%)
Market Cap: £978.40m
KNOS Live PriceLast checked at - London Stock Exchange

Intraday Kainos Group Share Chart

Share buyback programme

11 Nov 2024 07:01

RNS Number : 6114L
Kainos Group plc
11 November 2024
 

THE INFORMATION WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONTAIN INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. ‎UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA REGULATORY INFORMATION SERVICE, THIS INFORMATION IS ‎CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

 

11 November 2024

Kainos Group plc

("Kainos" or the "Company") 

 

Share buyback programme

Kainos Group plc, a UK-headquartered IT provider with expertise across three divisions - Digital Services, Workday Services and Workday Products, announces that, from today, it has appointed Investec Bank plc ("Investec") to manage a non-discretionary share buyback programme to purchase ordinary shares of £0.005 each in the capital of the Company ("Shares") within certain pre-set parameters, for up to a maximum amount of £30 million (excluding expenses) (the "Programme").

The Company has authorised the Programme to continue until the earlier of: (i) the date on which the maximum aggregate consideration payable by the Company has been reached and (ii) 11 May 2025.

The sole purpose of the Programme is to reduce the Company's share capital, and any Shares purchased for this purpose will be cancelled.

Rationale for Buyback Programme

As detailed in our half year results published this morning, Kainos has a strong unlevered balance sheet and continues to generate significant operating cash flow, with a net cash and treasury deposit balance of £151.6 million as of 30 September 2024.

The Programme is consistent with the Company's capital allocation policy, to enhance the growth of the business, both organically and through acquisition, and to reward shareholders through growth in earnings alongside our progressive dividend policy, while retaining a robust capital base. Where there is surplus cash over and above that needed to fund organic and inorganic growth, the Board will consider additional one-off returns of capital to shareholders.

 

In the context of the strong balance sheet position, the Board believes a share buyback to be an attractive use of capital to drive shareholder value alongside the significant ongoing organic investment.

The Board will continue to keep the capital allocation policy and further distributions to shareholders under review, with consideration of future buybacks and other potential uses of capital that may drive value for shareholders over the medium term.

The Programme will be conducted by the Company in accordance with and under the terms of the general authority granted to the Board by the Company's shareholders at the Company's annual general meeting on 24 September 2024 (the "General Authority") and, in line with the General Authority, will not exceed 12,584,171 Shares.

The Programme will be executed in accordance with Chapter 9 of the UK Listing Rules and the terms of the General Authority. The Programme will also be conducted within the parameters of the UK version of the Market Abuse Regulation (Regulation (EU) No 596/2014) as incorporated into UK domestic law by virtue of the European Union (Withdrawal) Act 2018. Investec will act as principal for the simultaneous on-sale of such shares to the Company and will make its trading decisions concerning the timing of the purchases of the Shares independently of the Company. Any purchase of Shares made in relation to the Programme will be carried out on the London Stock Exchange.

The Company will make further announcements following the completion of any purchases. There is no guarantee that the Programme will be implemented in full or that any Shares will be purchased by the Company.

The person responsible for arranging the release of this announcement on behalf of Kainos is Grainne Burns, Company Secretary.

Ends

 

For further information, please contact:

 

Kainos via FTI Consulting LLP

Russell Sloan, Chief Executive Officer

Richard McCann, Chief Financial Officer

 

Investec Bank plc +44 20 7597 5970

Patrick Robb / Nick Prowting / Ben Griffiths

 

FTI Consulting LLP +44 20 3727 1000

Dwight Burden / Kwaku Aning

 

About Kainos Group plc

Kainos Group plc is a UK-headquartered provider of sophisticated IT services to major public sector, commercial and healthcare customers. Our expertise spans three divisions: Digital Services, Workday Services, and Workday Products.

 

· Digital Services: We develop and support custom digital service platforms that transform service delivery in public, commercial, and healthcare sectors. Our solutions ensure security, accessibility, cost-effectiveness, and improved user outcomes.

· Workday Services: Specialising in deploying Workday, Inc.'s Finance, HR, and Planning products, we are a respected partner in Europe and North America. Experienced in complex deployments, we are trusted to launch, test, expand, and support Workday systems.

· Workday Products: Our established product suite, incorporating Smart Test, Smart Audit, and Smart Shield, complements Workday by enhancing system security and compliance. Our Employee Document Management product, launched in October 2023, improves document generation and storage within Workday while supporting an organisation's global compliance requirements. Over 500 global customers use one or more of our products.

Our people are central to our success. We employ more than 3,000 people in 20 countries across Europe, Asia and the Americas.

 

We are listed on the London Stock Exchange (LSE: KNOS) and you can discover more about us at www.kainos.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAFFPEEALFAA
Date   Source Headline
18th Nov 20213:34 pmRNSDirector/PDMR Shareholding
15th Nov 20217:00 amRNSKainos Half-year Report
1st Nov 20215:15 pmRNSTotal Voting Rights
1st Oct 202110:28 amRNSTotal Voting Rights
29th Sep 20213:33 pmRNSHolding(s) in Company
29th Sep 20211:18 pmRNSDirector/PDMR Shareholding
23rd Sep 20215:33 pmRNSAGM Results
23rd Sep 20215:30 pmRNSDirectorate Change
8th Sep 20213:15 pmRNSDirector/PDMR Shareholding
2nd Sep 202110:20 amRNSDirector/PDMR Shareholding
1st Sep 20215:38 pmRNSTotal Voting Rights
1st Sep 20217:00 amRNSAcquisition
1st Sep 20217:00 amRNSTrading Statement
25th Aug 20212:28 pmRNSDirector/PDMR Shareholding
18th Aug 202111:28 amRNSNotice of AGM
12th Aug 20212:05 pmRNSDirector/PDMR Shareholding
10th Aug 202112:41 pmRNSChange of Auditor
2nd Aug 202111:57 amRNSTotal Voting Rights
30th Jul 202112:25 pmRNSAnnual Financial Report
9th Jul 20216:31 pmRNSDirector/PDMR Shareholding
1st Jul 20214:35 pmRNSTotal Voting Rights
29th Jun 20213:58 pmRNSDirector/PDMR Shareholding
1st Jun 20217:00 amRNSAcquisition
24th May 20217:00 amRNSKainos Final Results
21st May 20217:00 amRNSBoard Changes
4th May 202111:49 amRNSTotal Voting Rights
16th Apr 20217:00 amRNSKainos Trading Statement
8th Apr 20213:51 pmRNSHolding(s) in Company
7th Apr 20214:02 pmRNSHolding(s) in Company
1st Apr 20214:23 pmRNSTotal Voting Rights
31st Mar 20214:14 pmRNSHolding(s) in Company
29th Mar 20214:16 pmRNSHolding(s) in Company
23rd Mar 20214:42 pmRNSHolding(s) in Company
11th Mar 20213:50 pmRNSHolding(s) in Company
1st Mar 202111:14 amRNSTotal Voting Rights
18th Feb 20214:26 pmRNSHolding(s) in Company
11th Feb 20213:28 pmRNSHolding(s) in Company
11th Feb 20212:12 pmRNSDirector/PDMR Shareholding
10th Feb 20215:00 pmRNSDirector/PDMR Shareholding
22nd Jan 20217:00 amRNSKainos Trading Update
31st Dec 202010:00 amRNSTotal Voting Rights
21st Dec 20207:00 amRNSKainos Appoint Independent Non-Executive Director
17th Dec 20204:05 pmRNSHolding(s) in Company
16th Dec 20206:06 pmRNSHolding(s) in Company
3rd Dec 20204:49 pmRNSDirector/PDMR Shareholding
1st Dec 20208:16 amRNSTotal Voting Rights
16th Nov 20207:00 amRNSKainos Group plc Interim results
14th Oct 20207:00 amRNSTrading Statement
24th Sep 202010:43 amRNSResult of AGM
3rd Sep 20207:00 amRNSKainos Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.